Neumora Therapeutics | IPO Presentation Deck

Slide schematic 6/6

callout 1/1 chart 2/2 paragraph 1/1 source-note 1/1 title 1/1

Components 6

primary line line paragraph source-note headline

Tools 1

Incorporating machine learning mediated ALS patient clustering from the Answer ALS (AALS) data set with NMRA-CK1δ transcriptomic drug signature enriches for subpopulations distinct patient population

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

market-segmentation-pyramid 60%

The slide describes segmenting a patient population into distinct groups based on drug signatures.

Find anything

MVAE stands for Multimodal Variational Autoencoder.